PGEN logo

Precigen (PGEN) Company Overview

Profile

Full Name:

Precigen, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

August 8, 2013

Indexes:

Not included

Description:

Precigen (PGEN) is a biotechnology company focused on developing innovative gene therapies and immunotherapies. They aim to treat various diseases, including cancer and genetic disorders, by using advanced technologies to modify genes and enhance the body’s immune response. Their goal is to improve patient outcomes through cutting-edge science.

Key Details

Price

$1.85

Annual Revenue

$6.22 M(-76.87% YoY)

Annual EPS

-$0.39(-378.57% YoY)

Annual ROE

-78.37%

Beta

1.59

Events Calendar

Earnings

Next earnings date:

Mar 19, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 14, 25 JMP Securities
Market Outperform
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 15, 24 JMP Securities
Market Outperform
Aug 15, 24 HC Wainwright & Co.
Buy
Jun 4, 24 JMP Securities
Market Outperform
Jun 3, 24 Stifel
Buy
Jun 3, 24 HC Wainwright & Co.
Buy
May 15, 24 Stifel
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Precigen?
  • Does Precigen pay dividends?
  • What sector is Precigen in?
  • What industry is Precigen in?
  • What country is Precigen based in?
  • When did Precigen go public?
  • Is Precigen in the S&P 500?
  • Is Precigen in the NASDAQ 100?
  • Is Precigen in the Dow Jones?
  • When was Precigen's last earnings report?
  • When does Precigen report earnings?
  • Should I buy Precigen stock now?

What is the ticker symbol for Precigen?

The ticker symbol for Precigen is NASDAQ:PGEN

Does Precigen pay dividends?

No, Precigen does not pay dividends

What sector is Precigen in?

Precigen is in the Healthcare sector

What industry is Precigen in?

Precigen is in the Biotechnology industry

What country is Precigen based in?

Precigen is headquartered in United States

When did Precigen go public?

Precigen's initial public offering (IPO) was on August 8, 2013

Is Precigen in the S&P 500?

No, Precigen is not included in the S&P 500 index

Is Precigen in the NASDAQ 100?

No, Precigen is not included in the NASDAQ 100 index

Is Precigen in the Dow Jones?

No, Precigen is not included in the Dow Jones index

When was Precigen's last earnings report?

Precigen's most recent earnings report was on Nov 14, 2024

When does Precigen report earnings?

The next expected earnings date for Precigen is Mar 19, 2025

Should I buy Precigen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions